Fig. 1From: Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapya Mechanism of PROTAC-mediated protein degradation. b Representative small-molecule ligands of E3s used for PROTAC. c Timeline and major milestones for the development of PROTACBack to article page